Skip to main content

US Retail Clinics Market Size to Surpass USD 6.36 Billion by 2030, exhibiting a CAGR of 12.5%

As per the report by Fortune Business Insights, the US retail clinics market size is projected to reach USD 6.36 billion in 2030, at a CAGR of 12.5% during the forecast period, 2023-2030

U.S. Retail Clinics Market

U.S. Retail Clinics Market Forecast (2023-2030)
U.S. Retail Clinics Market Forecast (2023-2030)

Pune, India, Oct. 06, 2023 (GLOBE NEWSWIRE) — The US retail clinics market is set to expand from USD 2.79 billion in 2023 to USD 6.36 billion by 2030, exhibiting a CAGR of 12.5% over the estimated period. The expansion is driven by the soaring focus of industry players on development of telemedicine services in healthcare establishments.

Fortune Business Insights™ provides this information in its research report, titled “U.S. Retail Clinics Market, 2023-2030”.

Key Industry Development:

March 2022 – Geisinger established a new clinical space at Susquehanna Valley Mall. The new facility would offer various services including laboratory, digestive and liver care, culinary medicine, clinical nutrition, radiology, laboratory, vascular surgery, and surgical specialties, and others.


Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-retail-clinics-market-106419


Key Takeaways:

  • The clinics provide preventative healthcare services and are helpful in treatment of minor illnesses.
  • U.S. retail clinics market is anticipated to experience growth, primarily due to the provision of timely medical intervention resulting in enhanced patient outcomes.
  • The expansion of services offered by clinics in the U.S. is expected to propel the U.S. retail clinics market growth.
  • The Segments is anticipated to register significant growth during the forecast period.

List of Key Players Profiled in the Report:

“Companies leading the US Retail Clinics Market are Walmart Inc. (U.S.), CVS Health (U.S.), Walgreens Boots Alliance, Inc. (U.S.), Kroger | The Kroger Co (U.S.), Kaiser Foundation Health Plan, Inc. (U.S.), Target Brands, Inc. (U.S.), Bellin Health Systems (U.S.), Geisinger Health (U.S.)”

Report Scope:

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR12.5%
2030 Value ProjectionUSD 6.36 Billion
Base Year2022
Market Size in 2022USD 2.71 Billion
Historical Data2019 to 2021
No. of Pages115
Segments coveredBy Service type, By Ownership, By Channel


To know how our report can help streamline your business, Speak To Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-retail-clinics-market-106419


Segments:

Immunization Segment Led the Market Due to Growing Usage for Vaccinating against Infectious Respiratory Diseases

On the basis of service type, the U.S. market for retail clinics is fragmented into acute respiratory infections, sore throat, conjunctivitis, urinary tract infections, immunization, screening services, and others. The immunization segment held the largest share in the market in 2022. The settings are considered popular for vaccine administration for infectious respiratory diseases including flu.

Retail-owned Operators Segment to Gain Traction Driven by Presence of Retail-owned Operators

By ownership, the U.S. market for retail clinics is categorized into independent operators, hospital-owned retailers, and retail-owned operators. The retailer-owned operators segment accounted for a dominant market share in 2022 and is estimated to grow at a considerable CAGR over the projected period. The rise is impelled by the robust presence of these operators in the country.


Retail Pharmacies Segment Dominated the Market Impelled by Robust Number of Patient Visits

On the basis of channel, the market is classified into groceries/retail stores, retail pharmacies, and others. The retail pharmacies segment held a key position in the market in 2022 and is poised to record appreciable growth over the study period. The expansion is driven by the robust number of patient visits to walk-in settings.

By Service Type

  • Acute Respiratory Infections
  • Sore Throat
  • Conjunctivitis
  • Urinary Tract Infections
  • Immunization
  • Screening Services
  • Others

By Ownership

  • Retailer-owned Operators
  • Independent Operators
  • Hospital-owned Operators

By Channel

  • Retail Pharmacies
  • Groceries/Retail Stores
  • Others


Quick Buy – US Retail Clinics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/106419


Drivers and Restraints:

Market Value to Rise due to Surging Inclusion of Diverse Healthcare Services

The U.S. retail clinics market growth is being propelled by the escalating inclusion of diverse healthcare services. This is on account of growing awareness associated with the benefits of preventive medical care and the need for enhanced and better medical intervention.

However, retail clinics do not have adequate provision for the treatment of complex diseases. This may hinder industry expansion to some extent.

Competitive Landscape:

Leading Companies Ink Partnership Deals to Increase Geographical Footprint

Major industry players are adopting various strategies for strengthening their positions in the U.S. retail clinics market share. These include partnership agreements, mergers, acquisitions, and the rollout of new products. Several retail clinics are also participating in health conferences to improve their offerings.


FAQs

How big is the retail clinic market in the US?

US Retail Clinics Market size is USD 2.79 billion in 2023 and it is expected to reach USD 6.36 billion in 2030.

How fast is the US retail clinics market growing?

The US Retail Clinics Market will exhibit a CAGR of 12.5% during the forecast period, 2023-2030.

Related Reports:

Retail Clinics Market Revenue, Size, Share, and Opportunities

U.S. Pharmacy Market Size, Share, Opportunities & Analysis
U.S. Reusable Medical Scrubs Market Share, Size, Demand, and Forecast

U.S. Substance Use Disorder Treatment Market 2023-2030, Size, Growth and Demand

U.S. Dermal Fillers Market Size, Share, Growth Industry Report


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

Contact Us:

Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.